Cited 56 times in
The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김경환 | - |
dc.contributor.author | 김현우 | - |
dc.contributor.author | 김현정 | - |
dc.contributor.author | 이병인 | - |
dc.contributor.author | 조경주 | - |
dc.contributor.author | 조양제 | - |
dc.date.accessioned | 2015-04-24T16:50:55Z | - |
dc.date.available | 2015-04-24T16:50:55Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 0969-9961 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/104287 | - |
dc.description.abstract | Recent studies demonstrate that matrix metalloproteinase-9 (MMP-9) is closely involved in the pathogenesis of epilepsy. This study investigated the role of MMP-9 in hippocampal cell death after pilocarpine-induced status epilepticus (SE). We showed that MMP-9 expression and activity significantly increased and beta1-integrin levels decreased on day 3 after SE. beta1-integrin degradation was also observed in hippocampal ex vivo extracts incubated with recombinant active MMP-9. Treatment with a selective MMP-9 inhibitor attenuated MMP-9 up-regulation, beta1-integrin degradation, the reduction of ILK activity and Akt phosphorylation, and subsequent hippocampal damage after SE. However, co-treatment with anti-beta1-integrin antibody almost completely blocked the protective effects of the MMP-9 inhibitor on both integrin-mediated survival signaling and hippocampal cell death. Our study demonstrates that MMP-9 induces apoptotic hippocampal cell death by interrupting integrin-mediated survival signaling after SE and suggests that MMP-9 may be a promising target for a neuroprotective approach to preventing seizure-induced hippocampal damage | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 169~180 | - |
dc.relation.isPartOf | NEUROBIOLOGY OF DISEASE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Analysis of Variance | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Antibodies/pharmacology | - |
dc.subject.MESH | Caspase 3/metabolism | - |
dc.subject.MESH | Cell Death/drug effects | - |
dc.subject.MESH | Cell Death/physiology | - |
dc.subject.MESH | Disease Models, Animal | - |
dc.subject.MESH | Dose-Response Relationship, Drug | - |
dc.subject.MESH | Enzyme Inhibitors/pharmacology | - |
dc.subject.MESH | Hippocampus/drug effects | - |
dc.subject.MESH | Hippocampus/metabolism* | - |
dc.subject.MESH | Hippocampus/physiopathology* | - |
dc.subject.MESH | In Situ Nick-End Labeling/methods | - |
dc.subject.MESH | Integrin beta1/immunology | - |
dc.subject.MESH | Integrin beta1/metabolism* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Matrix Metalloproteinase 2/metabolism | - |
dc.subject.MESH | Matrix Metalloproteinase 9/metabolism* | - |
dc.subject.MESH | Matrix Metalloproteinase Inhibitors | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Mice, Inbred C57BL | - |
dc.subject.MESH | Phosphopyruvate Hydratase/metabolism | - |
dc.subject.MESH | Propidium | - |
dc.subject.MESH | Signal Transduction/drug effects | - |
dc.subject.MESH | Statistics as Topic | - |
dc.subject.MESH | Status Epilepticus/chemically induced | - |
dc.subject.MESH | Status Epilepticus/drug therapy | - |
dc.subject.MESH | Status Epilepticus/pathology* | - |
dc.subject.MESH | Time Factors | - |
dc.subject.MESH | Up-Regulation/drug effects | - |
dc.title | The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Yonsei Biomedical Research Center (연세의생명연구원) | - |
dc.contributor.googleauthor | Gyung W. Kim | - |
dc.contributor.googleauthor | Hyun-Jeong Kim | - |
dc.contributor.googleauthor | Kyoung-Joo Cho | - |
dc.contributor.googleauthor | Hyun-Woo Kim | - |
dc.contributor.googleauthor | Yang-Je Cho | - |
dc.contributor.googleauthor | Byung I. Lee | - |
dc.identifier.doi | 10.1016/j.nbd.2009.07.008 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00310 | - |
dc.contributor.localId | A02797 | - |
dc.contributor.localId | A03804 | - |
dc.contributor.localId | A03851 | - |
dc.contributor.localId | A01130 | - |
dc.contributor.localId | A01125 | - |
dc.relation.journalcode | J02323 | - |
dc.identifier.eissn | 1095-953X | - |
dc.identifier.pmid | 19631748 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S096999610900179X | - |
dc.subject.keyword | Matrix metalloproteinase | - |
dc.subject.keyword | Integrins | - |
dc.subject.keyword | Pilocarpine | - |
dc.subject.keyword | Status epilepticus | - |
dc.contributor.alternativeName | Kim, Gyung Whan | - |
dc.contributor.alternativeName | Kim, Hyun Woo | - |
dc.contributor.alternativeName | Kim, Hyun Jeong | - |
dc.contributor.alternativeName | Lee, Byung In | - |
dc.contributor.alternativeName | Cho, Kyuong Joo | - |
dc.contributor.alternativeName | Cho, Yang Je | - |
dc.contributor.affiliatedAuthor | Kim, Gyung Whan | - |
dc.contributor.affiliatedAuthor | Lee, Byung In | - |
dc.contributor.affiliatedAuthor | Cho, Kyuong Joo | - |
dc.contributor.affiliatedAuthor | Cho, Yang Je | - |
dc.contributor.affiliatedAuthor | Kim, Hyun Jeong | - |
dc.contributor.affiliatedAuthor | Kim, Hyun Woo | - |
dc.citation.volume | 36 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 169 | - |
dc.citation.endPage | 180 | - |
dc.identifier.bibliographicCitation | NEUROBIOLOGY OF DISEASE, Vol.36(1) : 169-180, 2009 | - |
dc.identifier.rimsid | 56163 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.